Concord Drugs Ltd
Concord Drugs (BSE)


Proj. ROE (%)
Proj. P/E (x)
Proj EV / EBITDA (x)
Proj. P/BV (x)
Proj. Revenue ( Cr.)

Stock View

Share on
The average score for Concord Drugs Ltd stands at 6 against 9, three months back.

Concord Drugs Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of licensed drugs based on the formulations approved. The Company offers finished pharmaceutical formulations, such as injectables (small volume parenteral, dry powders), tissue bio-adhesive, tablets, capsules, liquid orals (syrup & suspension) and dry syrups (powder). The Company also provides ready-to-fill pellets and multiple unit pellets system (MUPS). Its pellets are categorized as gastrointestinal drug pellets, cardiovascular drug pellets, respiratory drug pellets, anti-obesity drug pellets, anti-depressant drug pellets, central nervous system drug pellets, urological drug pellets, anti-microbial, anti-infective and adjuvant drugs pellets, taste mask drug pellets/powder, nutrition and food supplement drug pellets, anti cholesterol drug pellets. It also provides Iso Amyl 2-Cyano Acrylate, which is a bio-adhesive product.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
100 DMA ()
200 DMA ()
52 Weeks Range
Street View :-
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity